AccScience Publishing / EJMO / Volume 4 / Issue 3 / DOI: 10.14744/ejmo.2020.28152
CASE REPORT

Neck Metastasis of Glioblastoma: A Rare Case

Andina Wirathmawati1 Yuyun Yueniwati2 Dessika Rahmawati1 Eko Arisetijono Marhaendraputro1 Shahdevi Nandar Kurniawan1
Show Less
1 Department of Neurology, Brawijaya University Faculty of Medicine, Malang, Indonesia
2 Department of Radiology, Brawijaya University Faculty of Medicine, Malang, Indonesia
EJMO 2020, 4(3), 239–245; https://doi.org/10.14744/ejmo.2020.28152
Submitted: 28 March 2020 | Accepted: 1 June 2020 | Published: 6 July 2020
© 2020 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Glioblastoma (GBM) is the most malignant primary intracranial tumor in adults. Metastases outside the central nervous system (CNS) are very rare. There are several factors for extracranial metastases, e.g. age at diagnosis, lifespan, surgical treatment, and chemoradiotherapy. We present a female patient with a glioblastoma single lesion neck metastasis on her left neck, who had tumor excision , radiotherapy, and chemotherapy and survived for four years.

Keywords
Glioblastoma
Extracranial
metastasis glioblastoma
Neck metastasis glioblastoma
Conflict of interest
None declared.
References

1.Rahmawati D, Marhaendraputro EA, Kurniawan SN, Wirathmawati A. Extracranial metastasis of glioblastoma: a rare case. Malang Neurology Journal 2019;5:51–54.

2. Haroon S and Faridi NF. Cervical metastatic glioblastoma multiforme. Journal of the College of Physicians and Surgeons Pakistan 2013;23:160–1.

3. Yueniwati Y. Pencitraan pada Tumor Otak. Universitas Brawijaya Press 2017.

4. Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P, Survival of adults with primary malignant brain tumors in Europe; results of the euro care-5 study. Euro care-5 Working Group: Eur J Cancer 2015;51:2231–2241.

5. Hoffman HJ, Duffner PK. Extra neural metastasis of central nervous system tumors. Cancer; 1985.1;56(7 Suppl):1778-82. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4027909

6. Catherine C, Park, et al. Systemic Metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol;2000.59:1044–50.

7. Piccirilli M, Brunetto GM, Rocchi G, Giangaspero F, Salvati M. Extra central nervous system metastasis from cerebral glioblastoma multiforme in elderly patients. Clinicopathological remarks on our series of seven cases and critical review of the literature. Tumor 2008;94:40–51. PubMed: https://www.ncbi. nlm.nih.gov/pubmed/18468334

8. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 2011;1:29:4175– 80.

9. Anghileri E, Castiglione M, Nunziata R, Boffano C, Nazzi V, Acerbi F, et al. Extra neural metastasis in glioblastoma patients: two cases with ykl-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev 2016;39:37–45; discussion 45–6.

10. Huang P, Allam A, Taghian A, Freeman J, Duffy M, Suit HD. Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in scid mice. J Neurosurg 1995;83:308–15. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7616277

11. Schweitzer T, Vince GH, Herbold C, Roosen K, Tonn JC. Extraneural metastases of primary brain tumors. J Neurooncol 2001;53:107–14. PubMed:https://www.ncbi.nlm.nih.gov/pubmed/11716064

12. Zustovich F, Della Puppa A, Scienza R, Anselmi P, Furlan C, Cartei G. Metastatic oligodendrogliomas: a review of the literature and case report. Acta Neurochir (Wien); 2008;150:699– 702; discussion 702–3.

13. Alam ABN, Rahayu M, Islani AZS. Effect of the radiation of gamma rays on caspase-3 expression in Rattus norvegicus Wistar male variant brain cell with immunohistochemistry method. Malang Neurology Journal 2015;1:72–9.

14. Tuettenberg J, Grobholz R, Korn T, Wenz F, Erber R, Vajkoczy P. Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme. J Cancer Res Clin Oncol 2005;131:31–40.

15. Cervio A, Piedimonte F, Salaberry J, Alcorta SC, Salvat J, Diez B, et al. Bone metastases from secondary glioblastoma multiforme: a case report. J Neurooncol 2001;52:141–8.

16. Kaye A, Laws Jr E. Brain tumors. Philadelphia: Churchill Livingstone; 2001.

17. Hsu E, Keene D, Ventureyra E, et al. Bone marrow metastasis in astrocytic glioma. J Neurooncol 1998;37:285–93. PubMed:https://www.ncbi.nlm.nih.gov/pubmed/9524086

18. Hiroko O and Paul K. Genetic pathways to Primary and Secondary Glioblastoma. The American Journal of Pathology; Vol 170 No May 5, 2007.

19. Butowski N, Chang S. Adult High-Grade Glioma. In: Barret GH. High-grade Glioma. New Jersey: Humana Press, 2007: p59-60

20. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Barnholtz-Sloan JS. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-Oncology 2015;17(Suppl. 4): iv1– v62.

21. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Barnholtz-Sloan J. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncology 2014;16(Suppl. 4): ivl–63.

22. Tamimi A.F and Jumeid M. Chapter 8 Epidemiology and outcome glioblastoma in Glioblastoma Bookshelf. De Vleeschouwer S, editor Brisbane (AU): Codon Publications; 2017 Sep 27.

23. Nizamutdinov D, Stock E.M, Dandashi J.A, et.al. Prognostication of survival outcomes in patients diagnosed with glioblastoma. World neurosurgery 109: E67-E74, January 2018.

24. Yueniwati Y, Wangsadjaja C, Yulidani I, Rianawati SB, Al Rasyid H. The role of Brain Magnetic Resonance Imaging (MRI) as an early detector of cognitive impairment. J Neurosci Rural Pract 2018;9:350–3.

25. Hiroko O and Paul K. Genetic pathways to Primary and Secondary Glioblastoma. The American Journal of Pathology; Vol 170 No 5, May 2007.

26. Kup PG, Nieder C, Winnekendonk G, Adamietz IA, Fakhrian K. Extracranial oral cavity metastasis from glioblastoma multiforme: A case report. Mol Clin Oncol 2016;5:437–9.

27. Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A, et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 2014;6:247ra101.

28. Singh G, Mehrotra A, Sardhara J, et.al. Multiple glioblastomas: are different from their solitary counterparts? Asian J Neurosurg 2015;10:266–271.

29. Ray A, Manjila S, Hdeib AM, Radhakrishnan A, Nock CJ, Cohen ML, et al. Extracranial metastasis of glioblastoma: three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol 2015;3:479–86.

30. Rosen J, Blau T, Grau S.J, et.al. Extracranial metastases of a cerebral glioblastoma: a case report and review of the literature. Case Rep Oncol 2018;11:591–600.

31. Izci Y, Akay KM, Gurkanlar D, Deveci MS. Radiation-induced glioblastoma multiforme following surgery for medulloblastoma in a child with neurofibromatosis-1: A Case report. Turk Neurosurg 2005;15:71–5.

32. Weiss L. A metastasizing ependymoma of the cauda equine. Cancer 1955;8:161–71.

33. Glioblastoma Multiforme. Aans.org.

34. Michael E.Berens and Alg Giese. “…those left behind.” Biology and Oncology of Invasive Glioma Cells. NEoplasia 1999:1:208– 19.

35. Ahmad Faleh Tamimi and Malik Juweid. Chapter 8: epidemiology and outcome of glioblastoma. Glioblastoma NCBI Bookshelf.

36. McLendon RE and Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 2003;98:1745–8.

37. Scott JN, Rewcastle NB, Brasher PM,e t.al. Long-term glioblastoma multiforme survivors: A population-based study. Can J Neurol Sci 1998;25:197–201.

38. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000:88:2887.

39. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 1987;21:607–14.

40. Myra E. van Linde, Cyrillo G. Brahm, et al. Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis. J Neurooncol 2017;135:183– 192.

 

Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing